QPharma

QPharma Recruits Managing Director to Lead Learning Management Business

http://bit.ly/2p0FKnv

qpharmacorp.com

http://bit.ly/2oMKKrE

Free Webinar: Managing a Well-Executed Product Launch - QPharma, Inc. QPharma Thought Leadership Series There are many challenges to successfully launching a product in today’s complex life sciences environment. Learn how to effect a successful outcome for your next product launch. Join QPharma’s own subject matter expert, Lori Peters, who will be moderating this spec...

FDA Drug Safety Communication: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children; recommends against use in breastfeeding women FDA is restricting the use of codeine and tramadol medicines in children. Codeine is approved to treat pain and cough, and tramadol is approved to treat pain. These medicines carry serious risks, including slowed or difficult breathing and death, which appear to be a greater risk in children younger...

QPharma, a premier provider of compliance and commercial services to the life sciences industry, has named Michael Strubbe, a 16-year veteran of the firm, to the role of Managing Director of Samples, Direct-to-Practitioner (DTP), and Fulfillment.

In this expanded position, Strubbe — who began his career with QPharma as an analyst, and later led its Account Management division — will oversee the continued enhancement of the company’s leading-edge technology platform and applications for sample management and fulfillment.



http://bit.ly/2nHgsVT

Longtime QPharma Veteran to Lead Sample Management Practice - QPharma, Inc. QPharma has named Michael Strubbe, a 16-year veteran of the firm, to the role of Managing Director of Samples, Direct-to-Practitioner, and Fulfillment.

QPharma maximizes the effectiveness of KOL engagements



http://bit.ly/2namtuN

KOL Engagement Solutions

Ti Spend™ is QPharma’s robust, cost-effective solution for tracking, evaluating, and reporting expense transactions in a compliant manner. With several states requiring pharmaceutical, medical device, and biologics industries to track and report on physician payments and promotional activities, the time to partner with the leader in aggregate spend solutions is now.

http://bit.ly/2na8oxp

Aggregate Spend Compliance and Reporting Solutions QPharma's proprietary tool for Sunshine Act compliance and Aggregate Spend reporting.

QPharma Case Study Series: DTP Program Review

http://bit.ly/2opoNhq

qpharmacorp.com

Free Webinar: Managing a Well-Executed Product Launch



http://bit.ly/2nWLl94

Free Webinar: Managing a Well-Executed Product Launch - QPharma, Inc. There are many challenges to successfully launching a product in today’s complex life sciences environment. Lori Peters, QPharma’s Senior VP of Commercial Operations, will be delivering a free webinar to discuss the importance of organized, enterprise-wide product launch management. QPharma has supp...

QPHARMA is HIRING! Quality Control Senior Specialist. Email resume with contact information to: [email protected]

QPHARMA is HIRING! VP/Managing Director of Professional Services. Email resume with contact information to: [email protected]

Join QPharma, FDA, and other industry experts at the 2017 Process Validation Summit in Philadelphia, PA.

QPharma's own Jeff Boatman and Scott Collins will be speaking at this event, so be sure not to miss it!

http://bit.ly/2m2OhAs

DATE & LOCATION:
May 18 to 19, 2017
Racquet Club of Philadelphia, PA

Are you compliant with FDA requirements for process validation? Today’s regulators are applying more fine-grained specifications and demanding more sophisticated procedures for planning, executing, and documenting your processes throughout a drug product’s lifecycle. This two-day intensive summit brings together industry leaders to help you exceed regulatory thresholds and avoid costly FDA inspection findings.

Early Bird Pricing: Register Now and Receive a $200 Discount

Click link below to register:
http://bit.ly/2m2OhAs

Strengthen Your Intelligence
Work with the product launch experts for affecting success for your next product launch. QPharma will partner with your product launch team by leveraging the cutting-edge technologies harnessed inside their highly intelligent enterprise SaaS solution, Ti Launch™.

QPharma Helps You Manage Your Product Launches using Ti Launch™

FDA Continues to Reduce Generic Drug Backlog
Posted 22 February 2017
By Zachary Brennan | RAPS.org

The US Food and Drug Administration (FDA) on Wednesday revealed that it approved more than 700 abbreviated new drug applications (ANDAs) for generic drugs in 2016, though the number of ANDAs pending an industry response also rose by more than 700. According to the most recent generic drug review dashboard, the number of ANDAs filed with no communications yet from FDA also fell from 581 ANDAs as of 1 January 2016 to 351 ANDAs as of 1 January 2017. -

See more at: http://www.raps.org/Regulatory-Focus/News/2017/02/22/26933/FDA-Continues-to-Reduce-Generic-Drug-Backlog/ .T3qo51i9.dpuf

FDA Continues to Reduce Generic Drug Backlog

QPharma Expands Client Base with Innovative KOL Influence Mapping Solution

Life Sciences Industry Leader Adds Top-25 Pharma Client

QPharma, a premier provider of compliance and commercial services to the life sciences industry, is expanding its client base for Key Opinion Leader (KOL) solutions. Recently, the firm was contracted by a top-25 pharmaceutical manufacturer for a seven-figure KOL influence mapping project.

QPharma’s KOL solution involves the comprehensive analysis and profiling of healthcare practitioners (HCPs) — as well as the practitioners to whom they are connected — to identify how best to engage them for pharmaceutical medical affairs and promotional purposes. QPharma analyzes all available HCP data sets, including professional, academic, and social as well as clinical activities, to provide clients with powerful insights about influential HCPs and their networks.

http://qpharmacorp.com/qpharma-expands-client-base-innovative-kol-influence-mapping-solution/

QPharma Expands Client Base with Innovative KOL Influence Mapping Solution - QPharma, Inc. Life Sciences Industry Leader Adds Top-25 Pharma Client

Ensure compliance with QPharma, the leader in learning management systems

New FDA Database Ensures Timely Access to Drug Safety Labeling Changes

http://www.aafp.org/news/practice-professional-issues/20170203safetylabels.html

New FDA Database Ensures Timely Access to Drug Safety Labeling Changes

Ti KOL™ and Ti Target™ - ENGAGE ONE, INFLUENCE MANY
How are you planning your medical communication strategy?

Ti Sample™ - Your Single Source for Compliant Sample Management

QPharma's Ti Sample™ software solution gives clients one-stop access to extensive reporting and reconciliation data. Our integrated practitioner validation service verifies practitioner licenses and eligibility to receive samples, while our auditing platform enables clients to audit and assess their programs to maintain PDMA compliance.

Whether you need a partner to interface seamlessly with your electronic SFA system or to provide scanning and data entry services for paper sample requests, QPharma can custom-tailor a sample management solution to accommodate any client's needs.

QPharma enhances its clients' sales and marketing efforts and supports whitespace coverage by offering alternative sampling and call center services. QPharma also offers comprehensive sample storage and fulfillment services for its clients seeking the ease, efficiency, and cost-effectiveness of an end-to-end logistics solution.

To learn more about QPharma’s Titanium™ Enterprise Suite of Commercial & Compliance SaaS solutions, please contact:

Ian Ségal
Manager of Marketing & Public Relations
QPharma, Inc.
22 South Street, Morristown, N.J. 07960
Tel - (973) 656-0011 • Email - [email protected]

QPharma KOL Thought Leadership
introducing Badal Shah, B.Pharm, M.S., M.B.A.
Director, Health Analytics

To learn more about Thought Leadership and QPharma’s subject matter experts, please contact:

Ian Ségal
Manager, Sales Operations & Marketing
Email: [email protected]
Phone: 973-656-0011

In addition to regulatory compliance and full product distribution solutions, QPharma® offers a comprehensive suite of distribution licensing services for pharmaceutical, medical device, and other life sciences firms. To operate in an efficient and compliant manner, life sciences firms must adhere to rigorous licensing processes — including keeping track of numerous state licensing agencies, completing and filing applications in a timely fashion, and staying abreast of an evolving mix of jurisdictional obligations.

QPharma’s seasoned team of regulatory specialists is at the ready to simplify and streamline your licensing activities. Our trained compliance personnel will work with you to satisfy prerequisites; identify and remediate all regulatory concerns; and prepare and file applications on your behalf — ensuring that you are fully licensed to distribute drugs, devices, biologics, and other healthcare products in all U.S. states and territories. Our state-of-the-art license maintenance technology solution, Ti License™, affords clients a 360-degree view into their nationwide licensure status, including applications, pending expirations, renewals, and more.

Whether you’re a small pharmaceutical or device company preparing for a product launch, or a major global manufacturer with thousands of brands, our distribution licensing experts have got you covered.

From: QPharma, Inc.

Your Trusted Health & Life Sciences Thought Leaders and Advisors

In the interest of keeping our clients informed of current industry regulations, this email is to inform you of the recent ordinance signed by the City of Chicago.

Please see Article VII, page 96 of the following:http://freepdfhosting.com/4ed4208552.pdf

It contains the details on a Chicago ordinance signed on November 16, 2016, that require Pharmaceutical Sales Representatives to have a license when promoting pharmaceutical products in the City of Chicago. The background of the ordinance is intended to reduce inappropriate opioid prescribing.

The ordinance which is similar in nature to the Washington, D.C. ordinance, will require sales representatives to undergo training for ethics, marketing regulations, and applicable laws. Representatives will also have to file reports with the city that disclose the names of doctors they visit as part of their work, the number of visits and any samples, materials, or gifts provided, along with their value.

Representatives will also have to pay a $750 licensing fee and renew the licenses annually.

The reporting period has not been established yet, but QPharma is monitoring the progress closely with the city and will continue to send out alerts.

If you have any questions or are interested in discussing the potential impact on your organization, please contact QPharma to schedule an appointment with one of our Subject Matter Experts by calling:

(973) 656-0011 or toll-free at (888) 742-7620

Looking forward to speaking with you!

Sincerely,

Ian Ségal


Ian Ségal | Sales Operations, Marketing, and Public Relations
QPharma, Inc. | 22 South Street | Morristown, New Jersey 07960
(tel) 973.656.0011 ext. 2081 (fax) 973.656.0408
[email protected]